Claims for Patent: 5,866,601

Summary for Patent: 5,866,601

Title:	Carbocyclic compounds
Abstract:	Novel carbocyclic compounds are described. The compounds generally comprise an acidic group, a basic group, a substituted amino or N-acyl and a group having an optionally hydroxylated alkane moiety. Pharmaceutical compositions comprising the inhibitors of the invention are also described. Methods of inhibiting neuraminidase in samples suspected of containing neuraminidase are also described. Antigenic materials, polymers, antibodies, conjugates of the compounds of the invention with labels, and assay methods for detecting neuraminidase activity are also described.
Inventor(s):	Lew; Willard (San Mateo, CA), Kim; Choung U. (San Carlos, CA), Liu; Hongtao (Foster City, CA), Williams; Matthew A. (Foster City, CA)
Assignee:	Gilead Sciences, Inc. (Foster City, CA)
Application Number:	08/476,946
Patent Claims:	1. A composition comprising a compound of formula (I) or (II): ##STR130## E.sub.1 is --(CR.sub.1 R.sub.1).sub.m1 W.sub.1 ; G.sub.1 is N.sub.3, --CN, --OH, --OR.sub.6a, --NO.sub.2, or --(CR.sub.1 R.sub.1).sub.m1 W.sub.2 ; T.sub.1 is --NR.sub.1 W.sub.3, a heterocycle, or is taken together with U.sub.1 or G.sub.1 to form a group having the structure ##STR131## U.sub.1 is H or --X.sub.1 W.sub.6 ; Each J.sub.1 is independently H, F or Cl; R.sub.1 is H or alkyl of 1 to 6 carbon atoms; R.sub.2 is R.sub.3 or R.sub.4 wherein each R.sub.4 is independently substituted with 0 to 3 R.sub.3 groups; R.sub.3 is F, Cl, Br, I, --CN, N.sub.3, --OR.sub.6a, --OR.sub.1, --N(R.sub.1).sub.2, --N(R.sub.1)(R.sub.6b), --N(R.sub.6b).sub.2, --SR.sub.1, --SR.sub.6a, --C(O)OR.sub.1, --C(O)OR.sub.6a, --OC(O)R.sub.1, --NR.sub.1 C(O)R.sub.1, --N(R.sub.6b)C(O)R.sub.1, --C(O)N(R.sub.1).sub.2, --C(O)N(R.sub.6b)(R.sub.1), --C(O)N(R.sub.6b).sub.2, --C(NR.sub.1)(N(R.sub.1).sub.2), --C(N(R.sub.6b))(N(R.sub.6b).sub.2), .dbd.O, .dbd.S, .dbd.N(R.sub.6b) or .dbd.N(R.sub.1); R.sub.4 is alkyl of 1 to 6 carbon atoms, alkenyl of 2 to 6 carbon atoms, or alkynyl of 2 to 6 carbon atoms; R.sub.5 is R.sub.4 wherein each R.sub.4 is substituted with 0 to 3 R.sub.3 groups; R.sub.6a is H or a protecting group for hydroxyl or thio; R.sub.6b is H or a protecting group for amino; W.sub.1 is a group comprising an acidic hydrogen or an R.sub.6a -protected acidic group; W.sub.2 is a group comprising a basic heteroatom or an R.sub.6b -protected basic heteroatom; W.sub.3 is W.sub.4 or W.sub.5 ; W.sub.4 is R.sub.5 or --C(O)R.sub.5, --C(O)W.sub.5, --SO.sub.2 R.sub.5, or --SO.sub.2 W.sub.5 ; W.sub.5 is carbocycle or heterocycle wherein each W.sub.5 is independently substituted with 0 to 3 R.sub.2 groups; W.sub.6 is R.sub.1, W.sub.5, --C(O)OR.sub.6a, --C(O)NR.sub.6b R.sub.6b, --C(NR.sub.6b)NR.sub.6b R.sub.6b, --C(S)NR.sub.6b R.sub.6b, --C(O)R.sub.1, --CHR.sub.1 W.sub.7, --CH(R.sub.1).sub.a W.sub.7 or --C(O)W.sub.7, where a is O or 1, but is O when W.sub.7 is divalent; W.sub.7 is R.sub.3 or an alkyl of 1 to 4 carbons substituted with 1 to 3 R.sub.3 groups; X.sub.1 is a bond, --CR.sub.1 R.sub.1 --, --(CR.sub.1 R.sub.1).sub.2 --, --O--, --NR.sub.1 --, --N(OR.sub.1)--, --N(NR.sub.1 R.sub.1)--, --S--, --SO--, or --SO.sub.2 --; and each m.sub.1 is independently an integer from 0 to 2; with the proviso that when: (a) E.sub.1 is --CO.sub.2 H, --P(O)(OH).sub.2, --NO.sub.2, --SO.sub.2 H, --SO.sub.3 H, tetrazolyl, --CH.sub.2 CHO, --CHO, or --CH(CHO).sub.2 ; (b) G.sub.1 is --CN, --NHR.sub.20, --OR.sub.20, guanidino, --N(R.sub.20)(OR.sub.20), --N(H)(R.sub.20)N(R.sub.20).sub.2, unsubstituted pyrimidinyl, or unsubstituted (pyrimidinyl)methyl; and (c) T.sub.1 is --NHR.sub.20, --SR.sub.20,--OR.sub.20, --CO.sub.2 R.sub.20, --NO.sub.2, --C(R.sub.20).sub.3, --CH.sub.2 CO.sub.2 R.sub.20, --CH.sub.2 NO.sub.2, or --CH.sub.2 NHR.sub.20 ; and R.sub.20 is H; an acyl group having 1 to 4 carbon atoms; a linear or cyclic alkyl group having 1 to 6 carbon atoms, or a halogen-substituted analogue thereof; an allyl group or an unsubstituted aryl group or an aryl substituted by a halogen, an OH group, an NO.sub.2 group, an NH.sub.2 group or a COOH group; (d) each J.sub.1 is H; and (e) X.sub.1 is a bond, --CH.sub.2 --or --CH.sub.2 CH.sub.2 --; then W.sub.6 is not H, W.sub.7 or --CH.sub.2 W.sub.7 wherein W.sub.7 is H, --OR.sub.6a, --OR.sub.1, --N(R.sub.1).sub.2, --N(R.sub.1)(R.sub.6b), --N(R.sub.6b).sub.2, --SR.sub.1, or --SR.sub.6a ; and the salts, solvates, resolved enantiomers and purified diastereomers thereof. 2. The composition of claim 1 wherein W.sub.1 is --CO.sub.2 R.sub.1, --SO.sub.3 R.sub.1, --S(O)OR.sub.1, --P(O)(OR.sub.1).sub.2, --C(O)--NH--SO.sub.2 --R.sub.4, --SO.sub.2 --NH--C(O)--R.sub.4 or tetrazolyl. 3. The composition of claim 1 wherein E.sub.1 is selected from the group consisting of: ##STR132## 4. The composition of claim 1 wherein W.sub.2 is amino, amidino, guanidino, heterocycle or an alkyl of 2 to 3 carbon atoms substituted with an amino and a second group selected from the group consisting of hydroxy and amino. 5. The composition of claim 1 wherein W.sub.2 is --NHR.sub.1, --C(NH)(NH.sub.2), --NR.sub.1 --C(NR.sub.1)(NR.sub.1 R.sub.3), --NH--C(NH)(NHR.sub.3), --NH--C(NH)(NHR.sub.1), --NH--C(NH)NH.sub.2), --CH(CH.sub.2 NHR.sub.1)(CH.sub.2 OH), --CH(CH.sub.2 NHR.sub.1)(CH.sub.2 NHR.sub.1), --CH(NHR.sub.1)--(CR.sub.1 R.sub.1).sub.m2 --CH(NHR.sub.1)R.sub.1, --CH(OH)--(CR.sub.1 R.sub.1).sub.m2 --CH(NHR.sub.1)R.sub.1, or --CH(NHR.sub.1)--(CR.sub.1 R.sub.1).sub.m2 --CH(OH)R.sub.1, --(CR.sub.1 R.sub.1).sub.m2 --S--C(NH)NH.sub.2, --N.dbd.C(NHR.sub.1)(R.sub.3) or --N.dbd.C(NHR.sub.1)(R.sub.1); wherein each m2 is independently an integer from 0 to 1. 6. The composition of claim 1 wherein G.sub.1 is selected from the group consisting of: ##STR133## 7. The composition of claim 1 wherein W.sub.3 is --C(O)--R.sub.5 or W.sub.5. 8. The composition of claim 7 wherein R.sub.5 is an alkyl of 1 to 4 carbon atoms substituted with 0 to 3 fluorine atoms. 9. The composition of claim 1 wherein W.sub.5 is selected from the group consisting of: ##STR134## 10. The composition of claim 1 wherein T.sub.1 is selected from the group consisting of: ##STR135## 11. The composition of claim 1 wherein X.sub.1 is --O--, --NH--, --S--, --SO--, or --SO.sub.2 --. 12. The composition of claim 1 wherein W.sub.6 is --CHR.sub.1 --W.sub.7 or --C(O)--W.sub.7. 13. The composition of claim 12 wherein W.sub.7 is --OR.sub.1 or an alkyl of 1 to 3 carbon atoms and is substituted with 1 to 3 hydroxy groups. 14. The composition of claim 1 wherein U.sub.1 is --O--CHR.sub.1 W.sub.7. 15. The composition of claim 14 wherein W.sub.7 is --OR.sub.1, or is an alkyl of 1 to 2 carbon atoms substituted with 1 to 2 hydroxy groups. 16. The composition of claim 1 wherein U.sub.1 is selected from the group consisting of: ##STR136## 17. The composition of claim 1 comprising a compound of the formula: ##STR137## wherein: E.sub.2 is selected from the group consisting of: ##STR138## G.sub.2 is selected from the group consisting of: ##STR139## T.sub.2 is an alkyl of 1 to 6 carbon atoms, alkenyl of 2 to 6 carbon atoms, or alkynyl of 2 to 6 carbon atom, with the proviso that T.sub.2 is substituted with 0 to 3 groups selected from the group consisting of F, Cl, Br, I, --CN, N.sub.3, --OR.sub.6a, --NR.sub.6b R.sub.6b, --SR.sub.6a, --O--C(O)R.sub.6a, or --NR.sub.6b --C(O)R.sub.6a ; U.sub.2 is a group selected from the group consisting of: ##STR140## and R.sub.7 is H, --OH, --OCH3, --OAc, --NH.sub.2, or --SH. 18. The composition of claim 1 further comprising a pharmaceuticallyacceptable carrier. 19. The composition of claim 1 which has formula (I). 20. The composition of claim 1 wherein the compound is of the formula: ##STR141## 21. The composition of claim 1 wherein U.sub.1 is --X.sub.1 W.sub.6. 22. The composition of claim 1 wherein X.sub.1 is --O--. 23. The composition of claim 1 wherein W.sub.6 is R.sub.1, W.sub.5, --CO.sub.2 R.sub.6a, --C(O)NR.sub.6b R.sub.6b, --C(NR.sub.6b)NR.sub.6b R.sub.6b, --C(S)NR.sub.6b R.sub.6b, --C(O)--R.sub.1, --CHR.sub.1 W.sub.7, --CH(R.sub.1).sub.a W.sub.7 (where a is 0 or 1, but is 0 when W.sub.7 is divalent) or --C(O)W.sub.7, wherein W.sub.7 is R.sub.3 or an alkyl of 1 to 4 carbons substituted with 1 to 3 R.sub.3 groups, typically selected from the group consisting of --NR.sub.1 (R.sub.6b), --N(R.sub.6b).sub.2, --OR.sub.6a, or SR.sub.6a. 24. The composition of claim 1 wherein W.sub.6 is R.sub.1. 25. The composition of claim 24 wherein R.sub.1 is a normal, secondary, tertiary or cyclic alkyl containing 1 to 6 carbon atoms. 26. The composition of claim 25 wherein R.sub.1 is --CH.sub.3, --CH.sub.2 CH.sub.3, --CH.sub.2 CH.sub.2 CH.sub.3, --CH(CH.sub.3).sub.2, --CH.sub.2 CH.sub.2 CH.sub.2 CH.sub.3, --CH.sub.2 CH(CH.sub.3).sub.2, --CH(CH.sub.3)CH.sub.2 CH.sub.3, --C(CH.sub.3).sub.3, --CH.sub.2 CH.sub.2 CH.sub.2 CH.sub.2 CH.sub.3, --CH(CH.sub.3)CH.sub.2 CH.sub.2 CH.sub.3, --CH(CH.sub.2 CH.sub.3).sub.2, --C(CH.sub.3).sub.2 CH.sub.2 CH.sub.3, --CH(CH.sub.3)CH(CH.sub.3).sub.2, --CH.sub.2 CH.sub.2 CH(CH.sub.3).sub.2, --CH.sub.2 CH(CH.sub.3)CH.sub.2 CH.sub.3, --CH.sub.2 CH.sub.2 CH.sub.2 CH.sub.2 CH.sub.2 CH.sub.3, --CH(CH.sub.3)CH.sub.2 CH.sub.2 CH.sub.2 CH.sub.3, --CH(CH.sub.2 CH.sub.3)(CH.sub.2 CH.sub.2 CH.sub.3), --C(CH.sub.3).sub.2 CH.sub.2 CH.sub.2 CH.sub.3, --CH(CH.sub.3)CH(CH.sub.3)CH.sub.2 CH.sub.3, --CH(CH.sub.3)CH.sub.2 CH(CH.sub.3).sub.2, --C(CH.sub.3)(CH.sub.2 CH.sub.3).sub.2, --CH(CH.sub.2 CH.sub.3)CH(CH.sub.3).sub.2, --C(CH.sub.3).sub.2 CH(CH.sub.3).sub.2, or --CH(CH.sub.3)C(CH.sub.3).sub.3. 27. The composition of claim 26 wherein W.sub.6 is (CH.sub.3 CH.sub.2)(CH.sub.3)CH--. 28. The composition of claim 26 wherein W.sub.6 is --CH(CH.sub.2 CH.sub.3).sub.2. 29. The composition of claim 1 wherein E.sub.1 is --CO.sub.2 R.sub.1. 30. The composition of claim 1 wherein G.sub.1 is --NH.sub.2. 31. The composition of claim 1 wherein T.sub.1 is R.sub.5 C(O)(H)N--.